Approval · Notice of Compliance 2239 · 2001
VIVELLE: Notice of Compliance 2239
Issued February 22, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2239
- Date
- February 22, 2001
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength
- Therapeutic class
- Estrogen
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VIVELLE | 02243488 | — |
Medicinal ingredients
- ESTRADIOL 2.16 MG per PAD